BNT162

Category

Upstate Medical University Selected by “Project Lightspeed” & Treats First Four Patients with BNT162 COVID-19 Vaccine

Upstate Medical University was selected by the Pfizer and BioNTech partnership to participate in the Phase 3 clinical trial assessing the safety and efficacy of the German company’s BNT162 vaccine targeting the novel coronavirus. Four vaccines in the BNT162 portfolio,...

Pfizer/BioNTech Select North Alabama Research Center & Sister Site Medical-Affiliated Research Center for Phase 3 BNT162 COVID-19 Vaccine Trial

North Alabama Research Center (NARC) and a sister site called Medical-Affiliated Research Center of Huntsville gear up to conduct major COVID-19 vaccine clinical trials sponsored by the BioNTech and Pfizer partnership. The site operation and study is overseen by Tonya...

Pin It on Pinterest